Patent ID: 6284804
Filing Date: 2001-09-04
Classification: A61K,A61P,Y10S

Abstract:
% (wt.) dexamethasone alcohol;b) 0.35% (wt.) ciprofloxacin hydrochloride, monohydrate;c) NaCI in an amount sufficient to cause the composition to have an osmolality of about 250-350 mOsm;d) 0.2% (wt.) hydroxyethyl cellulose;e) 0.05% (wt.) tyloxapol;f) a buffer comprising sodium acetate and acetic acid;g) 0.01% (wt.) benzalkonium chloride;h) 0.01% (wt.) edetate disodium;i) 0.6% (wt.) boric acid; andwherein the composition has a pH of 4.5.+-.0.